CHARLES SCHWAB INVESTMENT MANAGEMENT INC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 97 filers reported holding BRIDGEBIO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$27,853,971
+68.2%
1,056,275
+9.7%
0.01%
+60.0%
Q2 2023$16,562,757
+8.0%
962,951
+4.1%
0.01%0.0%
Q1 2023$15,333,549
+152.8%
924,822
+16.2%
0.01%
+150.0%
Q4 2022$6,066,427
-20.9%
796,119
+3.2%
0.00%
-33.3%
Q3 2022$7,671,000
-21.1%
771,656
-27.9%
0.00%0.0%
Q2 2022$9,718,000
-11.3%
1,070,159
-0.8%
0.00%0.0%
Q1 2022$10,953,000
-37.2%
1,079,082
+3.2%
0.00%
-40.0%
Q4 2021$17,436,000
-64.5%
1,045,290
-0.2%
0.01%
-68.8%
Q3 2021$49,096,000
+10.8%
1,047,492
+44.1%
0.02%
+6.7%
Q2 2021$44,323,000
+4.3%
727,082
+5.4%
0.02%
-6.2%
Q1 2021$42,476,000
+13.0%
689,532
+30.5%
0.02%
+6.7%
Q4 2020$37,578,000
+91.7%
528,443
+1.1%
0.02%
+66.7%
Q3 2020$19,606,000
+132.7%
522,543
+102.2%
0.01%
+125.0%
Q2 2020$8,427,000
+14.1%
258,411
+1.4%
0.00%0.0%
Q1 2020$7,387,000
+58.4%
254,718
+91.5%
0.00%
+33.3%
Q4 2019$4,663,000
+72.0%
133,031
+5.4%
0.00%
+50.0%
Q3 2019$2,711,000126,2430.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders